Evidence map›Paper›PMID 35945363›Full record

ArticleApplied microbiology and biotechnology2022

The role of the glycerol transporter channel Fps1p in cellular proteostasis during enhanced proteotoxic stress.

Kuljit Singh, Ratnika Sethi, Eshita Das, Ipsita Roy

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kuljit SinghPresent Address: Infectious Diseases Division, Indian Institute of Integrative Medicine (CSIR-IIIM), Canal Road, Jammu, 180001, India.
Ratnika SethiDepartment of Biotechnology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Sector 67, Punjab, 160062, India.
Eshita DasDepartment of Biotechnology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Sector 67, Punjab, 160062, India.
Ipsita RoyDepartment of Biotechnology, National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, Sector 67, Punjab, 160062, India. ipsita@niper.ac.in.ORCID http://orcid.org/0000-0003-1120-444X

Funding

Science and Engineering Research Board EMR/2014/001062
6 · The paper itself

Abstract

In response to osmotic shock, the components of high-osmolarity glycerol (HOG) pathway regulate the level of intracellular glycerol in yeast and ensure cell survival. Glycerol is a compatible solute and a stabiliser of proteins. Its role in maintaining proteostasis is less explored. We show that mild stress in the form of dietary restriction leads to increased glycerol level which increases cell viability. However, dietary restriction coupled with protein aggregation decreases intracellular glycerol level and attenuates cell viability. The transcript level of FPS1, the glycerol transporter channel, remains unchanged. However, its activity is altered under enhanced proteotoxic stress. Our results provide evidence for a probable role of the Fps1p channel in the cellular proteostasis network. KEY POINTS: • Dietary restriction led to increased accumulation of glycerol in Fps1-deleted yeast cells. • This led to lower protein aggregation in these cells. • Increased production of glycerol under dietary restriction was not linked to increased level of Fps1.

Indexed as

Membrane ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsGlycerolMembrane Transport ProteinsOsmotic PressureProtein AggregatesProteostasisFPS1 protein, S cerevisiaeGlycerolMembrane ProteinsMembrane Transport ProteinsProtein AggregatesSaccharomyces cerevisiae ProteinsCompatible osmolyteGlycerolHOG pathwayOsmoregulationProteostasis network

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.